Announced
Completed
AMBRX INC. / WUXI PHARMATECH (CAYMAN) INC. / SHANGHAI FOSUN PHARMACEUTICAL (GROUP) CO. LTD. / HOPU INVESTMENT MANAGEMENT COMANY LTD. / CHINA EVERBRIGHT LIMITED / VERSANT VENTURES / ROCHE VENTURE FUND / CMEA VENTURES / ARAVIS VENTURES / APPOSITE CAPITAL LLP / 5AM VENTURES LLC / Public / Acquisition
Financials
Transaction Value-
Consideration Type-
Capital Owned-
Capital Bid For100%
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-
Sources
Tags
pharmaceuticals
biotechnology
Biotechnology
United States
Acquisition
Public
Completed
Friendly
Single Bidder
Private Equity
Synopsis
Sale of Ambrx, a biopharmaceutical company engaged in the discovery, development, and commercialization of protein-based drugs, to a consortium of Chinese companies.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
No credit card required
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.